30233C0Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach
- Billable / Specific Code
30233C0 is a billable ICD-10-PCS procedure code for Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | 0 | Circulatory |
| 3 | Operation | 2 | Transfusion |
| 4 | BodySystem/Region | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | C | Hematopoietic Stem/Progenitor Cells, Genetically Modified |
| 7 | Qualifier | 0 | Autologous |
Code History
- 30233Y0 — Transfuse Autol Hemat Stem Cell in Periph Vein, Perc
- XW1337A — Transfuse Marnetegragene in Periph Vein, Perc, New Tech 10
- XW133B8 — Transfuse Betibeglogene in Periph Vein, Perc, New Tech 8
- XW133F8 — Transfuse OTL-103 in Periph Vein, Perc, New Tech 8
- XW133G8 — Transfuse OTL-200 in Periph Vein, Perc, New Tech 8
- XW133H9 — Transfuse Lovotibeglogene in Periph Vein, Perc, New Tech 9
- XW133J8 — Transfuse Exagamglogene in Periph Vein, Perc, New Tech 8
- XW133SB — Transfuse Mozafancogene in Periph Vein, Perc, New Tech 11
Similar Procedure Codes
Questions About 30233C0
Is 30233C0 a billable code?
Yes. 30233C0 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 30233C0 mean?
30233C0 breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character 0 is the Body System (Circulatory); the 3rd character 2 is the Operation (Transfusion); the 4th character 3 is the BodySystem/Region (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character C is the Substance (Hematopoietic Stem/Progenitor Cells, Genetically Modified); the 7th character 0 is the Qualifier (Autologous).
What MS-DRG does 30233C0 group to?
On an inpatient stay, Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach maps to MS-DRGs 016, 017, with relative weights from 4.8383 to 5.9297. The MS-DRG sets the fixed Medicare payment for the stay.
